Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Praxis (Bern 1994) ; 98(24): 1457-61, 2009 Dec 02.
Article in German | MEDLINE | ID: mdl-19953472

ABSTRACT

Calcific myonecrosis is a late complication of a previous trauma which presents as a calcified fusiforme mass on an x-ray film. It is affecting mostly the anterior compartment of the lower leg. 43 cases have been reported in the literature and are reviewed. The current authors report a case of calcific myonecrosis with calcific tenosynovitis of the tibialis anterior muscle. Precipitated hydroxyapatite crystals were found by ultrasound-guided aspiration, the lesion was then treated by injection of corticosteroids and an anesthetic.


Subject(s)
Ankle Injuries/complications , Ankle Joint/pathology , Athletic Injuries/complications , Calcinosis/diagnosis , Edema/etiology , Fibula/injuries , Gymnastics/injuries , Muscle, Skeletal/pathology , Osteoarthritis/diagnosis , Tibia/pathology , Tibial Fractures/complications , Aged , Ankle Injuries/therapy , Anterior Compartment Syndrome/complications , Athletic Injuries/therapy , Casts, Surgical/adverse effects , Diagnosis, Differential , Edema/diagnosis , Fibula/pathology , Humans , Male , Necrosis , Osteophyte/surgery , Postoperative Complications/diagnosis , Tendon Entrapment/diagnosis , Tibial Fractures/therapy , Tomography, X-Ray Computed , Ultrasonography
2.
Versicherungsmedizin ; 59(3): 115-9, 2007 Sep 01.
Article in German | MEDLINE | ID: mdl-17912884

ABSTRACT

The "metabolic syndrome" consists of some common risk factors for cardiovascular diseases: central obesity, diabetes mellitus, hyperlipidaemia and hypertension. The metabolic syndrome (MTS) leads to increased morbidity and mortality and to higher direct and indirect healthcare costs. The MTS can be diagnosed using the NCEP/ATP III criteria. The prevalence of the MTS in Germany is estimated at 23.8% and is expected to rise further, due to increasing obesity among children and adolescents. Studies have shown that the MTS leads to increased cardiovascular and total mortality and thus to a decreased life expectancy. Studies estimating the total costs of MTS are missing, but after addition of the costs for all the risk factors it is assumed that MTS costs amount to 5% of total healthcare costs. This is the result of the more frequent demand of health services and longer hospitalisation of patients with MTS. Even moderate weight loss can decrease the rates of morbidity and healthcare costs.


Subject(s)
Delivery of Health Care/economics , Delivery of Health Care/statistics & numerical data , Health Care Costs/statistics & numerical data , Metabolic Syndrome/economics , Metabolic Syndrome/mortality , Obesity/economics , Obesity/mortality , Comorbidity , Germany/epidemiology , Humans , Metabolic Syndrome/prevention & control , Obesity/prevention & control , Prevalence , Survival Analysis , Survival Rate
3.
Clin Nutr ; 25(2): 330-60, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16735082

ABSTRACT

Nutritional intake is often compromised in elderly, multimorbid patients. Enteral nutrition (EN) by means of oral nutritional supplements (ONS) and tube feeding (TF) offers the possibility to increase or to insure nutrient intake in case of insufficient oral food intake. The present guideline is intended to give evidence-based recommendations for the use of ONS and TF in geriatric patients. It was developed by an interdisciplinary expert group in accordance with officially accepted standards and is based on all relevant publications since 1985. The guideline was discussed and accepted in a consensus conference. EN by means of ONS is recommended for geriatric patients at nutritional risk, in case of multimorbidity and frailty, and following orthopaedic-surgical procedures. In elderly people at risk of undernutrition ONS improve nutritional status and reduce mortality. After orthopaedic-surgery ONS reduce unfavourable outcome. TF is clearly indicated in patients with neurologic dysphagia. In contrast, TF is not indicated in final disease states, including final dementia, and in order to facilitate patient care. Altogether, it is strongly recommended not to wait until severe undernutrition has developed, but to start EN therapy early, as soon as a nutritional risk becomes apparent.


Subject(s)
Enteral Nutrition/standards , Geriatrics/standards , Malnutrition/therapy , Practice Patterns, Physicians' , Aged , Aged, 80 and over , Europe , Humans , Quality of Life
4.
Clin Nutr ; 25(2): 180-6, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16697086

ABSTRACT

The ESPEN guidelines on enteral nutrition are the first evidence-based European recommendations for enteral nutrition. They were established by European experts for a variety of disease groups. During guideline development it became evident that terms and definitions in clinical nutrition have been used inconsistently depending on medical disciplines as well as regional and personal preferences. Therefore, to increase explanatory accuracy it was necessary to unify them. In this chapter terms and definitions used throughout all guidelines are explained. Additionally answers to more general questions, which might be important in most indications are dealt with, i.e. use of fibre containing and diabetes formulae.


Subject(s)
Enteral Nutrition/standards , Gastroenterology/standards , Practice Guidelines as Topic , Terminology as Topic , Enteral Nutrition/methods , Europe , Gastroenterology/methods , Humans
5.
Hypertens Pregnancy ; 21(2): 147-60, 2002.
Article in English | MEDLINE | ID: mdl-12175443

ABSTRACT

OBJECTIVE: Red blood cell (RBC) deformability is one of the factors determining microcirculation. In preeclampsia (PE) and some cases of intrauterine growth restriction (IUGR), microcirculation appears to be reduced. The aim of the study is to examine whether there are differences in RBC deformability in uncomplicated pregnancy when compared to pregnancies complicated by PE and/or IUGR. MATERIAL AND METHODS: RBC deformability of 87 pregnant women with initially normal pregnancies was evaluated with the laser diffractoscope. RBC deformability was measured beginning in week 16 of gestation up to 5 days after delivery. Thirty-seven women had an uncomplicated pregnancy. In addition, RBC deformability of 10 nonpregnant women was measured on days 5 and 22 of their menstrual cycle. RBC deformability of women with preeclampsia (PE, N=15), intrauterine growth restriction (IUGR, N=17), or PE plus IUGR (N=17) was measured weekly, beginning with the onset of clinical symptoms, up to 5 days after delivery. RESULTS: In early uncomplicated pregnancies, RBC deformability does not differ from the nonpregnant state. At week 30 of gestation, there is a slight decrease in RBC deformability followed by a return back to the values of nonpregnant women after delivery. Women with PE and/or IUGR show reduced RBC deformability. This is most pronounced in cases with severe fetal or maternal complications. After delivery, RBC deformability also returns to nonpregnancy values within 5 days. CONCLUSION: Reduced RBC deformability may contribute to a reduced microcirculation in PE and IUGR. Increasing RBC deformability therapeutically in these cases could offer new options for the treatment of decreased uterine and fetal perfusion and their sequelae.


Subject(s)
Erythrocyte Deformability , Fetal Growth Retardation/blood , Pre-Eclampsia/blood , Adult , Female , Gestational Age , Humans , Longitudinal Studies , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...